A Positive Outlook for Lynch Syndrome-Related Cancers External Web Site Icon B Benyon, Oncology Nursing News, May 11, 2019

Specific PHGKB|Cancer|PHGKB

What's New

Last Posted: May 13, 2019

---

• A Positive Outlook for Lynch Syndrome-Related Cancers  
  B Benyon, Oncology Nursing News, May 11, 2019
• Cancer and Women: Learn your family history of cancer and what you can do to lower your cancer risk
  CDC Cancer, May 2019
• Cancer Genetics and Epidemiology Video Library  
  NCI, 2019
• Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer.  
  Reinert Thomas et al. JAMA oncology 2019 May
• Can Circulating Tumor DNA in Early-Stage Colorectal Cancer Be More Than a Prognostic Biomarker?  
  Morris Van et al. JAMA oncology 2019 May
• Women’s Stories
  CDC Bring Your Brave Campaign, 2019
• A multigene assay determines risk of recurrence in patients with triple-negative breast cancer.  
  Stewart Rachel L et al. Cancer research 2019 May
• Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.  
  Sonpavde Guru et al. Cancer 2019 May 125(9) 1459-1469
• Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.  
  Elisei Rossella et al. Annales d'endocrinologie 2019 Apr
• ClinOmicsTrail  
  A visual analytics tool for breast cancer treatment stratification using multi-omics data
• ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification. 
  Schneider Lara et al. Bioinformatics (Oxford, England) 2019 Apr
• Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studies.  
  Hang Dong et al. International journal of epidemiology 2019 Apr
• Concept and benchmarks for assessing narrow-sense validity of genetic risk score values.  
  Yu Hongjie et al. The Prostate 2019 Apr
• Differences between screen-detected and interval breast cancers among BRCA mutation carriers.  
  Pilewskie Melissa et al. Breast cancer research and treatment 2019 May 175(1) 141-148
• ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.  
  Luchini C et al. Annals of oncology : official journal of the European Society for Medical Oncology 2019 May